﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Aidsmap news - English</title>
    <description> </description>
    <link>http://www.aidsmap.com/Aidsmap-news-English/page/1260794/</link>
    <language>en-gb</language>
    <copyright>NAM Publications - 2013</copyright>
    <pubDate>Wed, 19 Jun 2013 08:33:32 GMT</pubDate>
    <lastBuildDate>Wed, 19 Jun 2013 08:33:32 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Over half of people living with AIDS in San Francisco are aged 50 or older</title>
      <description>Over half of people living with an AIDS diagnosis in
San Francisco are aged 50 or older, investigators report in AIDS Care. The authors believe that the
Californian city “is the first local jurisdiction to have reached this
milestone”.&amp;#160;
Improvements in HIV treatment and care mean
that the prognosis of many HIV-positive people is now</description>
      <link>http://www.aidsmap.com/Over-half-of-people-living-with-AIDS-in-San-Francisco-are-aged-50-or-older/page/2679010/</link>
      <category>Ageing and HIV</category>
      <category>United States</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2679010/</guid>
      <pubDate>Tue, 18 Jun 2013 07:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Hyaluronic acid levels can predict risk of serious liver events in people living with HIV and hepatitis B or C co-infection</title>
      <description>A simple blood test can predict the risk of
liver-related death or hepatic encephalopathy for people living with HIV who have hepatitis B or hepatitis C co-infection, investigators from the EuroSIDA cohort report in PLoS One. Their results showed that
baseline elevations in plasma levels of hyaluronic acid (HA) were associated
with a</description>
      <link>http://www.aidsmap.com/Hyaluronic-acid-levels-can-predict-risk-of-serious-liver-events-in-people-living-with-HIV-and-hepatitis-B-or-C-co-infection/page/2669457/</link>
      <category>Hepatitis and HIV</category>
      <category>Other tests</category>
      <category>Outcomes and prognosis</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2669457/</guid>
      <pubDate>Mon, 17 Jun 2013 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>PrEP works for injecting drug users too</title>
      <description>A daily tablet of tenofovir, a drug otherwise used to treat
HIV infection, reduced the risk of HIV acquisition among people who inject
drugs by 49% in a clinical trial. Those who took the medication most
consistently had higher levels of protection, report scientists from the Centers
for Disease Prevention and Control (CDC) in</description>
      <link>http://www.aidsmap.com/PrEP-works-for-injecting-drug-users-too/page/2678439/</link>
      <category>HIV prevention policy</category>
      <category>Injecting drug use</category>
      <category>Injecting drug users</category>
      <category>Must see</category>
      <category>PrEP</category>
      <category>Thailand</category>
      <author>Roger Pebody</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2678439/</guid>
      <pubDate>Thu, 13 Jun 2013 22:40:00 GMT</pubDate>
    </item>
    <item>
      <title>Sexual health information is often inappropriate for Facebook sharing, say young people</title>
      <description>Sexual health promoters who wish to harness the power of
Facebook and other social media need to consider the role such websites play in young people’s presentations of themselves to others and the stigma of sexual health issues,
according to a small qualitative study published in the May issue of Reproductive Health</description>
      <link>http://www.aidsmap.com/Sexual-health-information-is-often-inappropriate-for-Facebook-sharing-say-young-people/page/2674545/</link>
      <category>Australia</category>
      <category>Behaviour change interventions</category>
      <category>Young people</category>
      <author>Roger Pebody</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2674545/</guid>
      <pubDate>Thu, 13 Jun 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Mobile phone support increases chances that people living with HIV will quit smoking</title>
      <description>Smoking cessation support delivered via
mobile phones increases chances that people living with HIV who smoke will quit, according to research
published in the online edition of Clinical
Infectious Diseases. Overall, people receiving mobile phone-based support
were over two times more likely to stop smoking than people receiving the
standard of care.
“The use of proactive</description>
      <link>http://www.aidsmap.com/Mobile-phone-support-increases-chances-that-people-living-with-HIV-will-quit-smoking/page/2669415/</link>
      <category>Smoking</category>
      <category>United States</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2669415/</guid>
      <pubDate>Wed, 12 Jun 2013 07:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Low CD4 cell count increases the risk of several cancers after starting HIV therapy</title>
      <description>A large US study has provided important new
insights into the incidence and timing of cancers among people taking
antiretroviral therapy. Published in the online edition of Clinical Infectious Diseases, the study showed that incidence of
AIDS-defining cancers was highest in the six months after starting HIV
therapy and then fell dramatically. In contrast,</description>
      <link>http://www.aidsmap.com/Low-CD4-cell-count-increases-the-risk-of-several-cancers-after-starting-HIV-therapy/page/2674629/</link>
      <category>Cancer</category>
      <category>Starting treatment</category>
      <category>United States</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2674629/</guid>
      <pubDate>Wed, 12 Jun 2013 07:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Undetectable viral load reduces the risk of HIV-associated anal cancer</title>
      <description>HIV therapy that effectively controls viral
load reduces the risk of anal cancer, US research published in the online
edition of the Journal of Acquired Immune
Deficiency Syndromes shows. The retrospective study involved almost 29,000 men taking combination antiretroviral therapy. Men with
viral suppression for at least 60% of the time while taking treatment</description>
      <link>http://www.aidsmap.com/Undetectable-viral-load-reduces-the-risk-of-HIV-associated-anal-cancer/page/2665425/</link>
      <category>Cancer</category>
      <category>CD4 count</category>
      <category>United States</category>
      <category>Viral load</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2665425/</guid>
      <pubDate>Tue, 11 Jun 2013 08:30:00 GMT</pubDate>
    </item>
    <item>
      <title>High rate of spontaneous disease regression in men with high-grade pre-cancerous anal lesions</title>
      <description>High-grade pre-cancerous anal lesions are
more likely to regress than progress, according to Australian research
published in the online edition of AIDS.
The study involved 574 men, three-quarters of whom were HIV positive. Only 1%
of patients progressed to anal cancer, compared to a regression rate of 24%.
“Our data provide reassurance that
high-grade ASILs [anal</description>
      <link>http://www.aidsmap.com/High-rate-of-spontaneous-disease-regression-in-men-with-high-grade-pre-cancerous-anal-lesions/page/2669529/</link>
      <category>Australia</category>
      <category>Cancer</category>
      <category>Men who have sex with men (MSM)</category>
      <category>Outcomes and prognosis</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2669529/</guid>
      <pubDate>Mon, 10 Jun 2013 15:10:00 GMT</pubDate>
    </item>
    <item>
      <title>Intimate partner violence associated with subsequent HIV infection in Uganda</title>
      <description>Ugandan women who have been subject to violence from a
sexual partner are more likely than other women to go on to acquire HIV,
according to a large, longitudinal study from the Rakai cohort, published in
the May 15 issue of AIDS. Women who
had experienced more severe forms of violence, more frequently, or</description>
      <link>http://www.aidsmap.com/Intimate-partner-violence-associated-with-subsequent-HIV-infection-in-Uganda/page/2672489/</link>
      <category>Epidemiology and behaviour</category>
      <category>Structural factors</category>
      <category>Uganda</category>
      <category>Women</category>
      <author>Roger Pebody</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2672489/</guid>
      <pubDate>Mon, 10 Jun 2013 11:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Combination prevention could "eliminate" HIV transmissions in Vietnam, model projects</title>
      <description>A “combination prevention” strategy with
targeted HIV testing and early antiretroviral therapy at its core has the
potential to virtually eliminate new HIV transmissions in Vietnam, according to
a mathematical model published in the online edition of the Journal of Acquired Immune Deficiency
Syndromes. The strategy had the biggest impact on transmissions and was
most</description>
      <link>http://www.aidsmap.com/Combination-prevention-could-eliminate-HIV-transmissions-in-Vietnam-model-projects/page/2670562/</link>
      <category>HIV prevention policy</category>
      <category>Infectiousness and treatment as prevention</category>
      <category>Injecting drug users</category>
      <category>Men who have sex with men (MSM)</category>
      <category>Sex workers</category>
      <category>Viet Nam</category>
      <author>Michael Carter</author>
      <guid isPermaLink="True">http://www.aidsmap.com/page/2670562/</guid>
      <pubDate>Fri, 07 Jun 2013 07:50:00 GMT</pubDate>
    </item>
  </channel>
</rss>